PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice
- 31 December 2011
- journal article
- research article
- Published by Elsevier BV in Experimental Neurology
- Vol. 232 (2), 333-338
- https://doi.org/10.1016/j.expneurol.2011.09.005
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Department of Defense
- National Institute of Child Health and Human Development Center
- Mallinckrodt Institute of Radiology
This publication has 24 references indexed in Scilit:
- Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant miceHuman Molecular Genetics, 2010
- Defective cAMP Generation Underlies the Sensitivity of CNS Neurons to Neurofibromatosis-1 HeterozygosityJournal of Neuroscience, 2010
- [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: A selective radioligand for dopamine D3receptors. II. Quantitative analysis of dopamine D3and D2receptor density ratio in the caudate-putamenSynapse, 2010
- [3H]4‐(Dimethylamino)‐N‐[4‐(4‐(2‐methoxyphenyl)piperazin‐ 1‐yl)butyl]benzamide, a selective radioligand for dopamine D3 receptors. I. In vitro characterizationSynapse, 2009
- Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1Jama-Journal Of The American Medical Association, 2008
- Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamineSynapse, 2005
- Proteomic Analysis Reveals Hyperactivation of the Mammalian Target of Rapamycin Pathway in Neurofibromatosis 1–Associated Human and Mouse Brain TumorsCancer Research, 2005
- Activity, non-selective attention and emotionality in dopamine D2/D3 receptor knock-out miceBehavioural Brain Research, 2002
- Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1Nature, 2002
- Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390Brain Research, 1986